Is It Normal to Start Bleeding Again 9 Days After Wisdom Teeth Removal

Cochrane Database Syst Rev. 2018 Mar; 2018(3): CD011930.

Interventions for treating mail service‐extraction bleeding

Monitoring Editor: Sumanth Kumbargere Nagraj, Eachempati Prashanti, Himanshi Aggarwal, Ashok Lingappa, Murugan S Muthu, Salian Kiran Kumar Krishanappa, Haszelini Hassan, and Cochrane Oral Health Group

Faculty of Dentistry, Melaka‐Manipal Medical College, Manipal Academy of College Instruction (MAHE), Manipal, Department of Oral Medicine and Oral Radiology, Jalan Batu Hampar, Bukit Baru, MelakaMalaysia, 75150

Faculty of Dentistry, Melaka‐Manipal Medical College, (Manipal Academy of Higher Education), Department of Prosthodontics, Jalan Batu Hampar, Bukit Baru, MelakaMalaysia, 75150

King George'south Medical University, Department of Prosthodontics, KGMU Campus, LucknowUttar PradeshIndia

Bapuji Dental Higher and Hospital, Oral Medicine & Radiology, DavangereKarnatakaIndia

Faculty of Dental Sciences, Sri Ramachandra University, Paediatric Dentistry, 2C Akme Park, Pedo Planet, Paediatric Dental Centre, OPP S&Due south POWER LTD,, PorurChennaiIndia, 600116

Faculty of Dentistry, Melaka Manipal Medical College (Manipal Academy of Higher Instruction), Department of Prosthodontics, Jalan Batu Hampar, MelakaMalaysia, 75150

International Islamic University Malaysia, Department of Oral Maxillofacial Surgery & Oral Diagnosis, Kulliyyah of Dentistry, Kuala LumpurMalaysia

Abstract

Background

Postal service‐extraction haemorrhage (PEB) is a recognised, frequently encountered complication in dental practice, which is divers equally haemorrhage that continues beyond 8 to 12 hours after dental extraction. The incidence of postal service‐extraction haemorrhage varies from 0% to 26%. If post‐extraction haemorrhage is not managed, complications can range from soft tissue haematomas to severe blood loss. Local causes of bleeding include soft tissue and bone bleeding. Systemic causes include platelet problems, coagulation disorders or excessive fibrinolysis, and inherited or acquired problems (medication induced). At that place is a broad assortment of techniques suggested for the treatment of post‐extraction bleeding, which include interventions aimed at both local and systemic causes. This is an update of a review published in June 2016.

Objectives

To assess the effects of interventions for treating different types of post‐extraction bleeding.

Search methods

Cochrane Oral Wellness's Data Specialist searched the following databases: Cochrane Oral Health's Trials Register (to 24 January 2018), the Cochrane Central Register of Controlled Trials (Cardinal) (the Cochrane Library, 2017, Event 12), MEDLINE Ovid (1946 to 24 January 2018), Embase Ovid (i May 2015 to 24 January 2018) and CINAHL EBSCO (1937 to 24 Jan 2018). The United states National Institutes of Wellness Trials Registry (ClinicalTrials.gov) and the Globe Health Organization International Clinical Trials Registry Platform were searched for ongoing trials. We searched the reference lists of relevant systematic reviews.

Selection criteria

We considered randomised controlled trials (RCTs) that evaluated any intervention for treating PEB, with male or female participants of any age, regardless of type of teeth (inductive or posterior, mandibular or maxillary). Trials could compare i blazon of intervention with some other, with placebo, or with no treatment.

Data collection and analysis

3 pairs of review authors independently screened search records. Nosotros obtained full papers for potentially relevant trials. If data had been extracted, we would have followed the methods described in the Cochrane Handbook for Systematic Reviews of Interventions for the statistical assay.

Main results

Nosotros did non find any randomised controlled trial suitable for inclusion in this review.

Authors' conclusions

Nosotros were unable to identify whatever reports of randomised controlled trials that evaluated the effects of different interventions for the treatment of mail‐extraction bleeding. In view of the lack of reliable bear witness on this topic, clinicians must use their clinical experience to make up one's mind the most appropriate means of treating this status, depending on patient‐related factors. There is a need for well designed and accordingly conducted clinical trials on this topic, which conform to the CONSORT argument (www.consort‐statement.org/).

Plain language summary

Interventions for managing bleeding after molar removal

Review question

We conducted this review to assess different interventions for treating bleeding later tooth removal.

Background

Later tooth extraction, it is normal for the expanse to bleed and then clot, generally within a few minutes. Information technology is abnormal if haemorrhage continues without clot formation, or lasts across 8 to 12 hours; this is known as postal service‐extraction haemorrhage (PEB). Such bleeding incidents can cause distress for patients, who might need emergency dental consultations and interventions. The causes of PEB can exist local, a systemic disease, or a medication. To command this bleeding, many local and systemic methods have been practised, based on the clinician'due south expertise. To inform clinicians well-nigh the all-time treatment, bear witness is needed from studies where people have been randomly allocated to 1 of at least two different groups, which receive different treatments, or no treatment (i.e. 'randomised controlled trials' or RCTs).

Study characteristics

Authors working with Cochrane Oral Health updated this review of RCTs that assess interventions to treat bleeding after tooth removal. The original review was published in June 2016. For this version, we searched the medical and dental literature to 24 January 2018. We found no RCTs that met the inclusion criteria for our review.

Key results and quality of the bear witness

This review revealed that there is no RCT evidence for the effectiveness of whatsoever available intervention for treating post‐extraction haemorrhage. High quality RCTs are needed to help clinicians and patients brand informed choices nearly treatment options.

Summary of findings

Background

Clarification of the status

Tooth removal, or extraction, is one of the about common invasive oral surgical procedures carried out in routine dental practise (Van Galen 2014), and mail service‐extraction haemorrhage is a recognised, oftentimes encountered complexity (McCormick 2014a). Immediately post-obit the removal of a tooth, bleeding or oozing commonly occurs. This bleeding can be easily controlled in about cases (Amer 2014), and almost completely stops within eight hours of extraction. However, sometimes information technology may continue, resulting in a life‐threatening state of affairs (Funayama 1994). It is important to distinguish between agile bleeding from the surgical site and oozing. The agile haemorrhage complication is normally termed 'mail service‐extraction bleeding' (PEB) or 'post‐operative bleeding after extraction'. Amer 2014 has described PEB as "evidence of bleeding beyond the pressure pack". Lockhart 2003 has provided 4 criteria to define PEB, namely that it:

1. continues beyond 12 hours;

2. causes the patient to call or return to the dental practitioner, or go to the blow and emergency department;

3. results in the evolution of a big haematoma or ecchymosis inside the oral soft tissues; or

4. requires a blood transfusion, hospitalisation, or both.

The rate of postoperative bleeding later extraction of mandibular third molars is 0.6% and after extraction of maxillary third molars is 0.four% (Chiapasco 1993). Jensen 1974 reviewed 103 cases of postoperative prolonged bleeding afterward oral surgery and reported that 75% of PEB occurred within 8 hours of the surgery, and only four patients had coagulation deficiencies. He besides reported that postoperative prolonged haemorrhage from the mandibular molars is more than common (80%) than bleeding from the maxillary molars (20%) because of the highly vascular floor of the mouth. Wells 2000 reported that the risk of prolonged haemorrhage was 0.2% to 1.four% in cases of third molar removal surgery. Iwabuchi 2014 reported two.77% clinically‐meaning PEB in patients receiving warfarin therapy, and 0.39% in non‐warfarin groups, regardless of the type of teeth (95% CI 0.65% to 4.10%). Kataoka 2016 reported that the incidence of PEB ranged from 0 to 26% in their cohort study. Yagyuu 2017 reported that the risk of postal service‐extraction bleeding was similar for patients on direct oral anticoagulants and Vitamin Yard antagonist extractions.

Post‐extraction haemorrhage has been attributed to various factors that tin be broadly classified as local and systemic (McDonnell 2013; Van Galen 2014). Post‐extraction haemorrhage can be caused locally, from soft tissue or bone haemorrhage. Soft tissue bleeding can exist due to traumatic extraction, leading to laceration of blood vessels (arterial, venous or capillary). Bone or osseous bleeding can be from either the nutrient canals or from the central vessels. Inflammation at the site of extraction, the presence of infection, traumatic extraction, and failure of the patient to follow post‐extraction instructions accept also been associated with PEB. Systemic factors include platelet issues, coagulation disorders or excessive fibrinolysis, and inherited or acquired problems (medication induced).

Post‐extraction bleeding can exist categorised equally primary prolonged bleeding, intermediate or reactionary prolonged bleeding, and secondary prolonged bleeding. Primary prolonged bleeding occurs during the extraction process, and may exist due to traumatic extraction leading to laceration of claret vessels, infections, such equally periapical granuloma, or injury to the os. Patients with chief prolonged bleeding nowadays with their mouth actively filling with blood immediately after removing the haemostatic dressing. Reactionary bleeding occurs a few hours postal service‐extraction and is more than mutual in patients with systemic disorders or patients on anticoagulant therapy. Secondary haemorrhage (liver clots) usually occurs vii to 10 days after extraction, and is a complication rarely encountered in dental do (Malik 2008; Table 2). Abdullah 2014 has classified PEB equally mild (oozing), moderate (bleeding persisting on the 2nd day of extraction), and severe (any haemorrhage that needed hospitalisation).

ane

Types of bleeding after dental extractions

Normal bleeding	Post‐extraction bleeding
	Principal	Reactionary	Secondary
Normally persists for upwardly to half an 60 minutes Oozing and blood tinged saliva for up to 8 hours Controlled by pressure pack	Occurs during and immediately subsequently extraction Typically presents as blood filling upward the mouth Usually due to infection or trauma to blood vessels Often controlled by local techniques like force per unit area packs, haemostatic agents, etc	Begins ii to three hours mail service extraction, after the vasoconstrictor issue of local amazement wears off Usually due to underlying systemic conditions such every bit bleeding or clotting disorders Not controlled by local measures and may require systemic interventions	Unremarkably begins 7 to 10 days post extraction Mainly due to secondary infection Rare in dental extractions, compared to the other two types of post‐extraction bleeding

In this review, we considered all the definitions and classifications described above as PEB.

Description of the intervention

The treatment of bleeding complications following a dental extraction is an essential skill for the dental practitioner (McCormick 2014b). Clinical decision making on how to command PEB depends on multiple factors, including the surgical location and site of bleeding, wound size, extent of haemorrhage, accessibility of the haemorrhage site, and timing of bleeding (Howe 2013). Furthermore, the selection of an intervention strategy to achieve haemostasis (blood clot germination at the site of vessel injury (Traver 2006)) likewise depends upon whether the patient is taking any medication or is suffering from any systemic disease, such as cirrhosis, that tin can affect bleeding and coagulation (McCormick 2014b).

Interventions for treating PEB can exist broadly categorised into local and systemic interventions. Local interventions can be farther subdivided into surgical interventions, non‐surgical interventions and a combination of both.

Local interventions

• Surgical intervention mainly involves suturing the extraction or bleeding site (Bajkin 2014; Van Galen 2014).

• Not‐surgical haemostatic measures, or styptics, encompass an array of pharmacotherapies, sealants, adhesives, absorbable agents, biologics, and combination products (Howe 2013). Common haemostatic agents used in oral surgery in extraction sites include the following (Al‐Belasy 2003; Mingarro‐de‐León A 2014): local pressure application with gauze, oxidised cellulose (Abdullah 2014), gel foam, thrombin, collagen fleeces (Baumann 2009), cyanoacrylate gum, acrylic or surgical splints (Anderson 2013), local antifibrinolytic solutions, such as tranexamic acrid mouthwash (Carter 2003), fibrin glue or adhesive (Cocero 2015), resorbable gelatin sponge, collagen sponge, gauze soaked with tranexamic acid (Perdigão 2012), chlorhexidine bio‐adhesive gel, calcium alginate (Scarano 2014), Haemocoagulase (Joshi 2014), Ankaferd Blood Stopper (Amer 2014), green tea extract (Soltani 2014), Chitosan‐based dressings (Pippi 2015; Sharma 2017), and bone wax.

• Various combinations of surgical and non‐surgical interventions have also been used, such as tranexamic acid mouthwash along with gelatin sponge and sutures, and fibrin glue with collagen fleece and sutures (Al‐Belasy 2003).

Systemic interventions

Systemic interventions are especially of import in patients who have an associated systemic cause for bleeding. The office of local haemostatics is limited in these cases, considering their utilise results in only temporary abeyance of bleeding (Auluck 2004). Systemic interventions include assistants of fresh frozen plasma (FFP), platelets, or both (Cocero 2015), cistron replacement therapy, using recombinant or plasma‐derived anti‐haemophilic factor A (FVIII) or anti‐haemophilic factor B or Christmas gene (Set up) in the case of haemophilia, and plasma‐derived Von Willebrand factor (VWF)/FVIII concentrates in the case of Von Willebrand disease (Anderson 2013), intranasal desmopressin (Stanca 2010), intravenous constructed vasopressin (Minkin 2015), oral or intravenous tranexamic acid (Morimoto 2004), oral or intravenous epsilon amino‐d‐caproic acid (Van Galen 2014). There are contradictory opinions on discontinuation of antithrombotic medications; for example, Aframian 2007 suggests the discontinuation of these medications, whereas Wahl 2016 suggests these medications for dental procedures should not be interrupted, equally the prognosis of potential post‐extraction bleeding that could upshot from antithrombotic continuation is improve than the prognosis of a potential stroke or center attack that could follow antithrombotic interruption.

How the intervention might work

Haemostasis, or control of haemorrhage, in the oral crenel is dependent on the dynamic remainder between fibrin formation and resolution and is influenced by the external environment, which contains both plasminogen and plasminogen activators (Carter 2003). It is a circuitous interaction between platelets, plasma proteins, and coagulation and fibrinolytic pathways. The clotting cascade involves the sequential activation of proenzymes in a stepwise response, which ultimately provides local generation of fibrin lattices that reinforce the platelet plug (Traver 2006). The coagulation procedure consists of three main phases: initiation, amplification, and propagation (Effigy 1; Glick 2013). The initiation phase begins with injury to the endothelium and tissue factor release, ultimately leading to thrombin formation. Platelet assemblage and activation occur during the amplification stage (Glick 2013), and provide the initial haemostatic response (Traver 2006). Finally, fibrin formation and stabilisation of the platelet clot occur during the propagation phase (Glick 2013).

Dissimilar phases of coagulation

Different interventions to command PEB basically interfere with the clotting cascade at different levels, resulting in cessation of haemorrhage. The mechanism of action of various interventions tin be broadly summarised, based on the different phases.

• Initiation phase: force per unit area packs, suture, bone wax, cellulose, styptics, gel cream, tranexamic acid, aminocaproic acrid, cryoprecipitate, desmopressin (DDAVP), factor VIII concentrate and prothrombin complex concentrate (PCC) act at different stages of this phase.

• Amplification stage: ethamsylate, haemostatic collagen and Actcell^® act during this phase.

• Propagation stage: cryoprecipitate and recombinant factor (VIIa) act during this stage.

Local interventions work either mechanically or past augmenting the coagulation cascade. Haemostatic agents act to stop bleeding past causing vasoconstriction or promoting platelet aggregation, whereas tissue adhesives or sealants bind to and close defects in tissue (Traver 2006). Systemic interventions work past inhibiting fibrinolysis or promoting coagulation (Van Galen 2014).

Why it is important to do this review

Cochrane Oral Health undertook an extensive prioritisation exercise in 2014 to identify a core portfolio of titles that were the well-nigh clinically important ones to maintain in the Cochrane Library (Worthington 2015). This review was identified as a priority title by the oral and maxillofacial surgery expert panel (Cochrane OHG priority review portfolio).

A wide array of techniques are suggested for the treatment of PEB and different guidelines have been published (Higginson 2007; Academy of Cambridge). Until our showtime version of this review in June 2016, there had been no Cochrane review to summarise the effects of the various interventions available to care for PEB and provide evidence to guide clinical dental practise. Because the unlike complex interventions addressing various upshot measures, it seems of import to attempt to describe the components of interventions and to identify constructive intervention strategies. A systematic review tin inform the implementation of unlike approaches and trigger the development of new interventions on the basis of current best show. A systematic review on this topic is also needed since interventions of questionable effectiveness and unclear consequences might be in use.

Objectives

To appraise the effects of interventions for treating unlike types of post‐extraction bleeding.

Methods

Criteria for considering studies for this review

Types of studies

We considered randomised controlled trials (RCTs) evaluating whatever intervention for treating post‐extraction haemorrhage (PEB). Nosotros excluded quasi‐RCTs, cross‐over trials and preventive trials. We had planned to include split‐mouth studies, provided in that location was no possibility of contamination. Dissever‐oral cavity blueprint is one of the self‐controlled study designs that is unique to dentistry. The design is characterised by subdividing the oral cavity of the subject area into homogeneous within‐patient experimental units such as quadrants, sextants, contralateral or ipsilateral quadrants or sextants, or a symmetrical combination of these.

Types of participants

We considered trials with participants of any age and either gender, who reported PEB, regardless of the type of teeth (anterior or posterior, mandibular or maxillary).

Types of interventions

We considered any surgical or non‐surgical technique or cloth used for the treatment of PEB. Nosotros had planned to make the following comparisons.

1. Direct comparisons of different interventions

2. Intervention versus placebo or no treatment

Types of event measures

Chief outcomes

1. Bleeding ‐ measured past:

• amount of blood loss;

• complete abeyance of haemorrhage, every bit assessed clinically by the investigator;

• time required for the command of haemorrhage.

Secondary outcomes

1. Patient‐reported outcomes related to pain or discomfort during the procedure;

2. Handling‐associated average cost;

3. Adverse effects.

Search methods for identification of studies

Electronic searches

Cochrane Oral Health's Data Specialist conducted systematic searches in the following databases for randomised controlled trials and controlled clinical trials without language or publication status restrictions:

• Cochrane Oral Health's Trials Annals (searched 24 January 2018) (Appendix 1);

• Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Upshot 12) in the Cochrane Library (searched 24 Jan 2018) (Appendix 2);

• MEDLINE Ovid (1946 to 24 January 2018) (Appendix iii);

• Embase Ovid (1 May 2015 to 24 January 2018) (Appendix 4);

• CINAHL EBSCO (Cumulative Alphabetize to Nursing and Allied Health Literature; 1937 to 24 Jan 2018) (Appendix v).

Subject strategies were modelled on the search strategy designed for MEDLINE Ovid. Where appropriate, they were combined with subject area strategy adaptations of the highly sensitive search strategy designed by Cochrane for identifying randomised controlled trials and controlled clinical trials as described in the Cochrane Handbook for Systematic Reviews of Interventions Affiliate vi (Lefebvre 2011).

Due to the Cochrane Centralised Search Project to place all clinical trials in the database and add them to CENTRAL, just well-nigh recent months of the Embase database were searched at the review's inception, and this search was updated for this version of the review. See the searching page on the Cochrane Oral Health website for more information. No other restrictions were placed on the appointment of publication when searching the electronic databases.

Searching other resources

The following trial registries were searched for ongoing studies:

• US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (clinicaltrials.gov; searched 24 January 2018) (Appendix half-dozen);

• World Health Organization International Clinical Trials Registry Platform (apps.who.int/trialsearch; searched 24 January 2018) (Appendix 7).

We searched the reference lists of relevant systematic reviews for further studies.

We did not perform a separate search for agin effects of interventions.

Data collection and analysis

Option of studies

Three pairs of review authors (Ashok L (AL) and Prashanti Eachempati (PE), Himanshi Aggarwal (HA) and Kiran Kumar (KK), and Muthu MS (MMS) and Haszelini Hassan (HH)), independently and in duplicate, screened the titles and abstracts from the electronic searches to identify potentially eligible studies. The search was designed to be sensitive and include controlled clinical trials; these were filtered out early in the choice process if they were not randomised. We obtained full‐text copies of all eligible and potentially eligible studies, which were independently evaluated by two authors (Sumanth Kumbargere Nagraj (SKN) and PE) . We resolved disagreements by word. When resolution was non possible, nosotros consulted an czar (Adinegara Lutfi Abas). We assessed articles in languages other than English after the abstracts had been translated (Table two). We did not detect whatsoever trials that fulfilled the inclusion criteria.

Data extraction and management

Nosotros had planned that two review authors (SKN, PE) would independently extract the data; and would non have been blinded to the authors. Nosotros would have resolved any disagreements by discussion betwixt the two review authors, if necessary, consulting a third review writer (PE) in order to reach consensus. Nosotros had planned to extract data using a customised data extraction form. All the items in the information extraction course were designed following guidance from the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). Nosotros would have entered study details into the 'Characteristics of included studies' table in Review Manager (RevMan) software (RevMan 2014), recording the following details for each included trial:

• publication details such as twelvemonth of publication, language;

• demographic details of the report;

• inclusion and exclusion criteria;

• type of trial, sample size, method of randomisation, resource allotment concealment, blinding, method of assessing the outcomes and drop‐outs, if any;

• type of intervention;

• details of the outcomes reported;

• duration of follow‐up;

• results of the intervention;

• funding details.

We had planned to write, email or telephone the contact author of included studies when clarification of details or additional data were required.

Assessment of risk of bias in included studies

Ii review authors (SKN and PE) had planned to independently appraise the risk of bias in the included trials in seven domains:

• random sequence generation (pick bias);

• allotment darkening (selection bias);

• blinding of participants and personnel (performance bias);

• blinding of outcome assessment (detection bias);

• incomplete outcome information (attrition bias);

• selective outcome reporting (reporting bias);

• other biases.

For each of these components, nosotros had planned to assign a judgment regarding the risk of bias as either high, low, or unclear based on guidance in Higgins 2011. Nosotros had planned to contact the trial authors if details were missing or unclear, and resolve disagreements through consensus. Nosotros had planned to record our judgements and justifications in 'Risk of bias' tables for each included study and generate a 'Risk of bias' summary graph and figure. We would have used these judgements to class the overall quality of show for each comparing and outcome in the 'Summary of findings' tables.

We had planned to summarise the take a chance of bias according to Higgins 2011; see Tabular array 3.

ii

Summarising the adventure of bias for a trunk of evidence

Risk of bias	Interpretation	In outcome	In included studies
Low hazard of bias	Plausible bias unlikely to seriously alter the results	Low take chances of bias for all key domains	Most information is from studies at low risk of bias
Unclear hazard of bias	Plausible bias that raises some doubt about the results	Unclear risk of bias for one or more fundamental domains	Most data is from studies at low or unclear risk of bias
High risk of bias	Plausible bias that seriously weakens confidence in the results	High run a risk of bias for one or more key domains	The proportion of information from studies at high take chances of bias is sufficient to affect the interpretation of results

Measures of treatment effect

We had expected our master outcome to exist expressed in dichotomous data. Nosotros would have expressed the upshot approximate as a risk ratio (RR) with 95% conviction intervals (CI). We had expected our secondary outcomes to be presented as dichotomous data, continuous data, or ordinal scales. We had planned to utilize ways and standard deviations to calculate mean differences and 95% CI for continuous information measured with the same scales and standardised mean differences if studies used different scales to measure the same outcome.

If data were expressed in ordinal scales, we had planned to explore the possibility of converting them to dichotomous outcomes. If outcomes were reported at baseline, trial endpoints, or follow‐up, we had planned to extract the mean modify and standard deviation from baseline for each handling group. We had intended to puddle either end scores or change scores, simply preferred stop scores when available; we would have combined end and alter scores where necessary.

We had planned to analyse data expressed as counts (number of bleeding incidents) in the same way as continuous information.

Unit of analysis bug

Nosotros expected two types of non‐standard study designs in this review:

• multiple treatment groups;

• dissever‐mouth design

We were expecting information related to repeated ascertainment on participants for our secondary outcome of fourth dimension required for the control of bleeding. In this case, nosotros had planned to follow the method described in department 9.iii.4 of the Cochrane Handbook (Higgins 2011).

In trials where adverse effects were described as counts, we wanted to follow the method described in section ix.2.5 of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). In the case of dropouts, nosotros had planned to use what the paper reports and deal with information technology in the 'Chance of bias' assessment. Nosotros were not expecting to notice any cluster‐randomised trials for this status.

Dealing with missing data

Nosotros had planned to contact written report authors to obtain missing data. We would accept used the methods outlined in section xvi.1.2 of the Cochrane Handbook for Systematic Reviews of Interventions to calculate missing standard deviations. If it had not been possible to calculate the SDs, nosotros would have described the outcomes qualitatively (Higgins 2011).

Assessment of heterogeneity

If meta‐analyses were performed, we would take assessed heterogeneity using a Chi² test, where a P value < 0.1 indicated statistically significant heterogeneity. We would have quantified heterogeneity using the I² statistic equally follows:

• 0% to 40% implies slight heterogeneity;

• 30% to 60% moderate heterogeneity;

• fifty% to 90% substantial heterogeneity;

• 75% to 100% considerable heterogeneity.

If there was considerable heterogeneity (I² > 75%), which could non be explained by the subgroup analyses, we planned not to conduct meta‐analysis. We had planned to translate I² values between 0% to xl% every bit peradventure insignificant, 30% to threescore% every bit perchance significant, 50% to 90% every bit possibly substantial, and 75% to 100% as maybe very substantial ('considerable'); depending on whether the inconsistency in results was due to differences in the direction of effect estimates between trials rather than due to differences in the magnitude of upshot estimates favouring an intervention (Deeks 2011).

Assessment of reporting biases

If there were more than ten studies included in a meta‐analysis, we had planned to assess the possible presence of reporting bias by testing for asymmetry in a funnel plot. If present, we would have carried out statistical analyses using the methods described by Egger 1997.

Data synthesis

We had planned to analyse the information using RevMan software (RevMan 2014). If the data available from the studies had similar comparisons and outcomes, we would have undertaken a meta‐analysis. Our full general approach would accept been to employ a random‐effects model. With this approach, the CIs for the average intervention effect are wider than those obtained using a fixed‐effect approach, leading to a more conservative interpretation. We wanted to utilise all end scores or all alter scores when available, but would have combined end and change scores where necessary, using the criteria in department 9.4.5.2 of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). We had planned to report the results from studies not included in a meta‐analysis in boosted tables.

Subgroup analysis and investigation of heterogeneity

If there was significant heterogeneity, we had planned to explore the reasons by performing the following subgroup analyses based on different groups of patients. The subgroups were to be divided based on:

• type of PEB (master, reactionary, or secondary);

• type of extraction (surgical or forceps);

• type of underlying bleeding or clotting disorder (deficiency of factors, qualitative disorders, vessel disorders);

• drug history (anticoagulant, antiplatelet, or combination);

• type of teeth (deciduous or permanent, mobile or house, maxillary or mandibular, anterior or posterior).

Sensitivity analysis

If there were sufficient included studies, nosotros would take undertaken sensitivity analysis based on take chances of bias, including only studies at low risk of bias.

Summarising findings and assessing the quality of the evidence

We had planned to use the Course arroyo to interpret findings (Schunemann 2008). We had planned to utilise GRADE Profiler software (GRADEpro GDT 2014), and import data from RevMan 2014 to create 'Summary of findings' tables for each comparison included in the review. These tables were to provide information apropos the overall quality of the evidence from the trials, the magnitude of result of the interventions examined, and the sum of available data on the primary and secondary outcomes. The Class approach considers 'quality' to be a judgment of the extent to which we can be confident that the estimates of effect are correct (Schunemann 2008). A body of prove from randomised controlled studies is initially graded equally high and downgraded past one or ii levels on each of v domains, afterward full consideration of: whatever limitations in the blueprint of the studies, the directness (or applicability) of the evidence, the consistency of results, precision of the results, and the possibility of publication bias. A quality level of 'high' reflects confidence that the true effect lies close to that of the judge of the outcome for an outcome. A sentence of 'moderate' quality indicates that the true effect is probable to be shut to the judge of the effect, simply acknowledges the possibility that it could exist essentially different. 'Low' and 'very low' quality testify limit our confidence in the effect estimate (Balshem 2011).

Results

Description of studies

Nosotros found no published or ongoing randomised controlled trials that evaluated interventions for treating mail‐extraction bleeding.

Results of the search

Our search strategy identified 1916 titles and abstracts of studies up to 24 January 2018. These were independently assessed for relevance past 3 pairs of review authors (AL and PE; HA and KK; MMS and HH). Nosotros checked the reference lists of the excluded studies and added another 24 references. After removal of duplicates, we had a total of 1187 records. We rejected 1147 based on the abstracts. We obtained full texts for other forty trials. Twenty‐eight of these were not RCTs (studies not in English that we translated are listed in Appendix viii). Nosotros excluded the other 12 trials for reasons described below. None of the trials met the inclusion criteria for our review (Figure 2).

Included studies

Nosotros did not find any studies suitable for inclusion.

Hazard of bias in included studies

No trials were included.

Effects of interventions

See: Table 1

Summary of findings for the main comparison

Summary of findings for interventions to treat mail service‐extraction bleeding

Interventions for treating postal service‐extraction bleeding
Patient or population: people with post‐extraction bleeding Settings: hospital or dental practise
Outcomes	Illustrative comparative risks* (95% CI)		Relative effect (95% CI)	No of Participants (studies)	Quality of the bear witness (Class)	Comments
	Assumed risk	Corresponding adventure
Bleeding, every bit measured by: amount of blood loss; complete cessation of bleeding, as assessed clinically by the investigator; time required for the control of bleeding.	No data are available as no RCTs take been conducted on interventions to treat post‐extraction bleeding
Patient‐reported outcomes related to pain or discomfort during the procedure
Handling‐associated boilerplate toll
Agin events
*The basis for the causeless hazard (e.m. the median command group risk beyond studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: confidence interval
GRADE Working Group grades of show Loftier quality: Further research is very unlikely to change our confidence in the estimate of event. Moderate quality: Further research is likely to have an important impact on our confidence in the guess of result and may change the approximate. Low quality: Further research is very likely to take an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: We are very uncertain about the estimate.

No studies fulfilled our inclusion criteria.

Word

Post‐extraction bleeding (PEB) is ane of the treatment complications of dental extraction that might brand a patient panic and seek firsthand dental consultation. With the increasing number of patients on anticoagulant therapy with aspirin, warfarin, and clopidogrel, the chance of encountering PEB is increasing. Commonly, these people are aware of their medical status and report their medical history. It is normal to utilize precautionary measures to prevent PEB in such patients. All the same, this may not be the state of affairs in low‐ and middle‐income countries, where the majority of patients may not give a proper medical and drug history, and medical records may not be accessible. Hence, it is of import to know how to control PEB in cases where no preventive measures were used.

Post‐extraction bleeding can also occur due to local or systemic problems that are not expected in routine dental extractions. We exercise not have whatever evidence‐based guidelines to manage such cases. The nowadays review aimed to appraise the effects of various interventions for the treatment of different types of PEB.

Nosotros did non find whatsoever suitable trials to include in our review. This is because almost of the trials advocated preventive measures prior to and immediately after extraction, and reported either the incidence of PEB or tested preventive measures. Most of these trials reported the management of PEB based on clinician experience. Several trials tested whether anticoagulants, antiplatelets, or antifibrinolytics should be stopped earlier dental extraction, and reported varying incidence rates of PEB in control and intervention groups.

The majority of the preventive trials randomised extraction cases into intervention groups. An ideal trial for this review would randomise PEB (primary or reactionary or secondary) cases instead.

This topic seems to be an unexplored area of primary enquiry. We found one observational trial in a High german clinical trial annals in which postoperative bleeding incidents later dental treatment in patients with and without anticoagulant therapy were studied (DRKS00009286). We institute no non‐Cochrane systematic reviews on this topic. We identified two narrative reviews based on the authors' opinions (Leonard 1995; McCormick 2014a). We found two websites that have published guidelines to manage PEB (Emed handbook past Higginson 2007; Academy of Cambridge).

We observed the term 'postal service‐extraction bleeding' being used in different means. Joshi 2014 used PEB terminology to describe the normal bleeding that happens afterwards dental extraction in their written report. Al‐Bahlani 2001 describes whatsoever type of bleeding after dental extraction equally postoperative haemorrhage. This tin can create defoliation and there is a need to standardise PEB terminology and its definition.

Authors' conclusions

Implications for practice

We identified no published or ongoing randomised controlled clinical trials on interventions to treat post‐extraction bleeding, and then information technology is non possible to present evidence to clinicians or patients. In the absence of any bear witness from randomised controlled trials, clinicians should base their decisions on clinical feel, in conjunction with evidence from preventive trials.

Implications for research

In that location is a demand for robust clinical trials to evaluate the effects of interventions for the treatment of PEB. Future randomised controlled trials should focus on interventions to control bleeding in patients after the extraction, and in whom no preventive interventions have been advocated. This will help usa understand the best intervention strategy to be used if an emergency situation arises postal service‐extraction, to control primary, secondary or reactionary haemorrhage. Because the varying incidence of PEB (0% to 26%), multicentric trials to accomplish appropriate sample size (ability of the report) should exist conducted. Any future trials should exist well designed and reported according to the Consort statement (http://www.consort‐argument.org/).

What's new

Engagement	Event	Description
14 May 2018	Review declared equally stable	At that place are no completed or ongoing randomised controlled trials on this topic.

History

Protocol first published: Issue 10, 2015
Review first published: Issue 6, 2016

Date	Effect	Description
21 February 2018	New commendation required but conclusions take not changed	We excluded an boosted three trials.
24 January 2018	New search has been performed	We updated our search to 20 February 2018. We made pocket-size changes to update the Background.

Notes

This review will no longer exist updated as there are no completed or ongoing randomised controlled trials evaluating treatments for post‐extraction bleeding.

Acknowledgements

The authors would like to thank Pradeep Kumar for screening the titles and abstracts for the previous version of this review.

The authors thank Ms. Anne Littlewood, Information Specialist, Ms. Janet Lear, Administrator, Ms. Laura CI MacDonald, Managing Editor, and Ms. Helen Wakeford, Deputy Managing Editor, all of Cochrane Oral Health. We thank Philip Riley and Ruth Floate for their comments. Nosotros also thank Ms. Shazana Binti Mohd Selva, Chief Librarian, Dr. Venkatachalapathy Suram, Professor, Professor DoctorAdinegara Lutfi Abas, Dean, Faculty of Medicine, Professor Dr. Abdul Rashid Haji Ismail, Dean, Faculty of Dentistry, Melaka Manipal Medical College, Manipal University of Higher Education, Melaka, Malaysia, and Professor Dr. Ravi Kant, Vice Chancellor, Male monarch George'south Medical Academy, Lucknow, Bharat for all the suggestions and assist during the review preparation. Nosotros also thank Dr. Naresh Yedthare Shetty, Senior Lecturer, International Medical University, Kuala Lumpur for his valuable suggestions.

We admit the help of foreign language translators Joanna Zajac, Malgorzata Bala, Paul Tramini, Lilia Ziganshina, Karin Rau, Anette Blümle, Anna Misyail Abdul Rashid, Loh Zheng Tao, Giovanni Lodi, Andrea Pokorna, Maddalena Manfredi, Ubai Alsharif, Dr Liyuan Ma, Professor Chengge Hua, and Professor Zongdao Shi.

Appendices

Appendix 1. Cochrane Oral Wellness'south Trials Register search strategy

1. ((tooth or teeth or molar* or bicuspid* or cuspid* or incisor*):ti,ab) AND (INREGISTER)

2. ((extract* or remov* or surgery):ti,ab) AND (INREGISTER)

3. (#i and #two) AND (INREGISTER)

4. ((bleed* or "blood loss" or hemorrhag* or haemorrhag* or hemorrag* or haemorrag*):ti,ab) AND (INREGISTER)

5. (#3 and #4) AND (INREGISTER)

Appendix 2. The Cochrane Central Register of Controlled Trials (CENTRAL) search strategy

#one [mh ^"Molar extraction"]
#2 [mh Tooth]
#iii (tooth or teeth or tooth* or bicuspid* or cuspid* or incisor*)
#four [mh ^"Tooth, impacted"]
#5 {or #ii‐#4}
#6 (extract* or remov* or surgery)
#7 #5 and #vi
#8 #ane or #7
#9 [mh ^"Blood loss, surgical"]
#10 [mh ^"Postoperative hemorrhage"]
#11 [mh ^"Hemorrhagic disorders"]
#12 [mh ^"Oral hemorrhage"]
#13 (drain* or "claret loss" or hemorrhag* or haemorrhag* or hemorrag* haemorrag*)
#fourteen {or #9‐#13}
#15 #viii and #14

Appendix 3. MEDLINE Ovid search strategy

1. Tooth extraction/
ii. exp Tooth/
iii. (molar or teeth or molar$ or bicuspid$ or cuspid$ or incisor$).ti,ab.
four. Tooth, impacted/
five. or/2‐iv
half-dozen. (extract$ or remov$ or surgery).ti,ab.
7. 5 and 6
eight. 1 or 7
9. Blood loss, surgical/
x. Postoperative hemorrhage/
11. Hemorrhagic disorders/
12. Oral hemorrhage/
13. (bleed$ or "claret loss" or hemorrhag$ or haemorrhag$ or hemorrag$ or haemorrag$).ti,ab.
14. or/nine‐13
fifteen. 8 and 14

This subject search was linked to the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomised trials in MEDLINE: sensitivity‐maximising version (2008 revision) as referenced in Chapter 6.4.eleven.1 and detailed in box half-dozen.4.c of The Cochrane Handbook for Systematic Reviews of Interventions, Version 5.one.0 [updated March 2011] (Lefebvre 2011).

1. randomized controlled trial.pt.
2. controlled clinical trial.pt.
three. randomized.ab.
iv. placebo.ab.
5. drug therapy.fs.
half dozen. randomly.ab.
vii. trial.ab.
8. groups.ab.
9. or/ane‐8
x. exp animals/ not humans.sh.
eleven. 9 non ten

Appendix 4. Embase Ovid search strategy

1. Tooth extraction/
2. exp Tooth/
three. (tooth or teeth or molar$ or bicuspid$ or cuspid$ or incisor$).ti,ab.
4. 2 or 3
5. (extract$ or remov$ or surgery).ti,ab.
6. iv and v
vii. 1 or six
eight. Haemorrhage/
nine. Bleeding disorder/
x. Oral bleeding/
eleven. (bleed$ or "claret loss" or hemorrhag$ or haemorrhag$ or hemorrag$ or haemorrag$).ti,ab.
12. or/viii‐11
13. 7 and 12

This subject search was linked to an adapted version of the Cochrane Centralised Search Project filter for identifying RCTs in Embase Ovid (come across http://world wide web.cochranelibrary.com/help/central‐cosmos‐details.html for information):

1. Randomized controlled trial/
two. Controlled clinical study/
three. Random$.ti,ab.
4. randomization/
five. intermethod comparison/
6. placebo.ti,ab.
7. (compare or compared or comparing).ti.
viii. ((evaluated or evaluate or evaluating or assessed or assess) and (compare or compared or comparing or comparison)).ab.
9. (open up adj label).ti,ab.
x. ((double or unmarried or doubly or singly) adj (blind or blinded or blindly)).ti,ab.
11. double blind procedure/
12. parallel group$ane.ti,ab.
13. (crossover or cross over).ti,ab.
14. ((assign$ or match or matched or allotment) adj5 (alternate or group$1 or intervention$1 or patient$1 or subject$1 or participant$1)).ti,ab.
fifteen. (assigned or allocated).ti,ab.
16. (controlled adj7 (study or pattern or trial)).ti,ab.
17. (volunteer or volunteers).ti,ab.
xviii. trial.ti.
19. or/one‐xviii
20. (exp brute/ or beast.hw. or nonhuman/) not (exp man/ or human cell/ or (human or humans).ti.)
21. nineteen non 20

Appendix 5. CINAHL EBSCO search strategy

S13 S8 and S12
S12 S9 or S10 or S11
S11 (bleed* or "blood loss" or hemorrhag* or haemorrhag* or hemorrag* haemorrag*)
S10 (MH "Postoperative Hemorrhage")
S9 (MH "Blood Loss, Surgical")
S8 S1 or S7
S7 S5 and S6
S6 (excerpt* or remov* or surgery)
S5 S2 or S3 or S4
S4 (MH "Tooth, Impacted")
S3 (tooth or teeth or molar* or bicuspid* or cuspid* or incisor*)
S2 (MH "Tooth+")
S1 (MH "Molar Extraction")

This subject search was linked to Cochrane Oral Health's filter for CINAHL EBSCO:

S1 MH Random Assignment or MH Single‐blind Studies or MH Double‐bullheaded Studies or MH Triple‐blind Studies or MH Crossover design or MH Factorial Blueprint
S2 TI ("multicentre study" or "multicenter study" or "multi‐middle report" or "multi‐center study") or AB ("multicentre study" or "multicenter written report" or "multi‐centre study" or "multi‐eye written report") or SU ("multicentre study" or "multicenter study" or "multi‐heart study" or "multi‐heart study")
S3 TI random* or AB random*
S4 AB "latin foursquare" or TI "latin square"
S5 TI (crossover or cross‐over) or AB (crossover or cross‐over) or SU (crossover or cross‐over)
S6 MH Placebos
S7 AB (singl* or doubl* or trebl* or tripl*) or TI (singl* or doubl* or trebl* or tripl*)
S8 TI blind* or AB mask* or AB bullheaded* or TI mask*
S9 S7 and S8
S10 TI Placebo* or AB Placebo* or SU Placebo*
S11 MH Clinical Trials
S12 TI (Clinical AND Trial) or AB (Clinical AND Trial) or SU (Clinical AND Trial)
S13 S1 or S2 or S3 or S4 or S5 or S6 or S9 or S10 or S11 or S12

Appendix vi. US National Institutes of Health Trials Registry (ClinicalTrials.gov) search strategy

"oral surgery" and bleed

"oral surgery" and hemorrhage

tooth and extraction and bleed

tooth and extraction and hemorrhage

Appendix 7. The WHO International Clinical Trials Registry Platform search strategy

Oral surgery and drain

Oral surgery and hemorrhage

Oral surgery and haemorrhage

Tooth extraction and drain

Molar extraction and hemorrhage

Tooth extraction and haemorrhage

Appendix 8. Studies we translated and rejected as ineligible for inclusion

Trial identification	Championship	Language	Translator/southward	Reasons for rejection
Trentalancia 1967	The apply of 5‐oxytryptamine in mail‐extraction haemorrhages	Italian	Giovanni Lodi	1. The study is not randomised. Randomisation is never mentioned. The author stated that "the patients accept been divided as follows" (page 1386). 2. Patients were at take a chance of haemorrhage, and not with post‐extraction bleeding.
Pavek 1976	Evaluation of the haemostatic effect of Dicynon in dentoalveolar surgery	Czech	Andrea Pokorna	The study does non fulfil criteria as information technology describes awarding of Dicynone in iv groups of patients – no randomisation, no detailed clarification of the patient groups.
Szpirglas 1979	Stomatological haemorrhages; haemostasis with GRF (gelatin‐resorcin‐formol)	Italian	Maddalena Manfredi	This written report is a description of a topical haemostasis technique without any study about patients.
Marini 1966	Therapy of postal service‐extraction haemorrhages in haemophiliac patients with epsilon‐aminocaproic acrid (EACA).	Italian	Maddalena Manfredi	This is a instance series.
Torteli 1965	Use of "reptilase" in postoperative bleeding of the dental apparatus	German	Ubai Alsharif	This is a case series of 14 patients who were treated with Raptilase, and does not fulfil the inclusion criteria.
Zhou 1985	Prevention and treatment of haemorrhage after extraction of teeth by using the pulvis of cibotium barometz‐alum fire	Chinese	Dr Liyuan Ma, Professors Chengge Hua, Zongdao Shi and Mr.Loh Zheng Tao	The trial is a RCT with 2 arms; however, the randomisation method is not reported. This is a preventive report for reducing post‐extraction complications including PEB, instead of managing post‐extraction haemorrhage.
Antoszewski 1972	Cepevit‐K grooming in controlling haemorrhages and bleeding post-obit tooth extraction	Polish	Joanna Zajac and Malgorzata Bala	Non a randomised controlled trial. They used Cepevit‐Yard: ‐ afterward extraction for 22 patients (for 17, bleeding was stopped within eight minutes; chirurgical treatment was provided for the others). ‐ 2 days before extraction in 18 patients with low coagulation time (for 4 patients in this grouping, additional chirurgical treatment was needed). The merely comparison is 20 other people with bleeding afterwards tooth extraction, where the author used other techniques (other than chirurgical treatment); it simply worked for eight patients, so the other 12 were given Cepevit‐K.
Fetkowska‐Mielnik 1969	Clinical evaluation of the results of treatment of mail‐extraction haemorrhage with new drugs E.A.C.A., styptanon	Shine	Joanna Zajac and Malgorzata Bala	Not a randomised controlled trial. Study was based on ascertainment of 69 patients, all with claret coagulation problems: some after extraction with haemorrhage, some before extraction. For all blood analyses were done and according to results: ‐ for some: epsilon aminocaproic acid (EACA) was used ‐ for others: Styptanon was used ‐ for others: EACA and Styptanon together
Khomiachenko 1978	Use of aminocaproic acid for stopping the bleeding subsequently tooth extraction	Russian	Lilia Ziganshina and Anna Misyail Abdul Rashid	This is an abstract describing 100% success of 5% aminocapronic acrid in 135 patients. This was not a trial; in that location was no comparison.
Neuner 1968	Therapy of bleeding post-obit extractions	German	Karin Rau and Anette Bluemle	This is not a randomised control trial. In this publication, the interventions for postal service‐extraction bleeding are explained in item, simply not within the scope of a clinical study.
Saltykova 1974	The apply of new haemostatic drug in dental practice	Russian	Lilia Ziganshina and Anna Misyail Abdul Rashid	This is a single instance report.
Martineau 1989	Hemorrhage in the dental office. Study of local haemostatic treatment	French	Paul Tramini	This newspaper is just a recommendation for practitioners and students in example of PEB problems. No information are available.
Rokicka‐Milewska 1966	Application of epsilon‐aminocaproic acid for oral mucosal haemorrhage in haemophiliacs	Smooth	Joanna Zajac and Malgorzata Bala	This article is not a RCT. All participants (13 children with haemophilia: 9 blazon A and 4 type B) received epsilon‐aminocaproic (20% solution) acrid 24 hours before tooth extraction. Intolerance adult in some children, so the dose was changed (from 0.1 g/kg of body weight to 0.05g/kg), or the drug was administered intravenously.

Notes

Stable (no update expected for reasons given in 'What's new')

Characteristics of studies

Characteristics of excluded studies [ordered by report ID]

Differences between protocol and review

We changed the title from 'managing' to 'treating'. We made this change throughout equally 'managing' could be interpreted equally including prevention, which was non our intention.

Figure ane in the protocol has been modified to Table i in the review ('Types of bleeding afterward dental extractions').

Principal and secondary outcomes are re‐worded without irresolute the meaning.

We had mentioned under selection of studies that 2 pairs of review authors would independently screen the titles and abstracts to identify potentially eligible studies. However, iii pairs of review authors screened the titles and abstracts.

As nosotros did not accept any included trials, the contribution of authors differed from what nosotros had planned.

Contributions of authors

• Sumanth Kumbargere Nagraj: drafting the protocol, evaluation of full text articles for inclusion or exclusion, drafting the final review, and updating the review.

• Eachempati Prashanti: drafting the protocol, screening titles and abstracts, evaluation of full text manufactures for inclusion or exclusion and updating the review.

• Himanshi Aggarwal: drafting the protocol, screening titles and abstracts, and drafting the final review.

• Ashok Lingappa: content skillful, screening titles and abstracts.

• Murugan Southward Muthu: content expert, screening titles and abstracts, and drafting the terminal review.

• Salian Kiran Kumar Krishanappa: undertaking searches, screening titles and abstracts.

• Haszelini Hassan: content practiced, screening titles and abstracts, and drafting the concluding review.

Sources of support

Internal sources

• Kinesthesia of Dentistry, Melaka Manipal Medical College, Manipal University, Melaka Campus, Malaysia.

  Library support and providing preparation in Cochrane Systematic Reviews

External sources

• National Found for Health Research (NIHR), United kingdom of great britain and northern ireland.

  This project was supported past the NIHR, via Cochrane Infrastructure funding to Cochrane Oral Health. The views and opinions expressed therein are those of the authors and practise not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Wellness.

• Cochrane Oral Health Global Alliance, Other.

  The production of Cochrane Oral Health reviews has been supported financially by our Global Brotherhood since 2011 (oralhealth.cochrane.org/partnerships‐alliances). Contributors over the by yr accept been the American Association of Public Health Dentistry, U.s.a.; Equally‐Akademie, Germany; the British Association for the Written report of Community Dentistry, Great britain; the British Guild of Paediatric Dentistry, U.k.; the Canadian Dental Hygienists Association, Canada; the Centre for Dental Educational activity and Research at All India Constitute of Medical Sciences, India; the National Middle for Dental Hygiene Enquiry & Practise, USA; New York University College of Dentistry, USA; and NHS Educational activity for Scotland, UK; Swiss Society of Endodontology, Switzerland.

Declarations of interest

Sumanth Kumbargere Nagraj: no interests to declare
Eachempati Prashanti: no interests to declare
Himanshi Aggarwal: no interests to declare
Ashok Lingappa: no interests to declare
Murugan S Muthu: no interests to declare
Salian Kiran Kumar Krishanappa: no interests to declare
Haszelini Hassan: no interests to declare

References

References to studies excluded from this review

Ak 2012 {published data only}

• Ak Grand, Alpkılıç Başkırt E, Kürklü E, Koray M, Tanyeri H, Zülfikar B. The evaluation of fibrin sealants and tissue adhesives in oral surgery among patients with bleeding disorders. Turkish Journal of Hematology 2012;29(1):forty‐vii. [PMC free article] [PubMed] [Google Scholar]

Al‐Mubarak 2006 {published information only}

• Al‐Mubarak S, Rass MA, Alsuwyed A, Alabdulaaly A, Ciancio S. Thromboembolic risk and bleeding in patients maintaining or stopping oral anticoagulant therapy during dental extraction. Journal of Thrombosis and Haemostasis 2006;4(3):689‐91. [PubMed] [Google Scholar]

Carter 2003 {published data simply}

• Carter G, Goss A, Lloyd J, Tocchetti R. Tranexamic acid mouthwash versus autologous fibrin gum in patients taking warfarin undergoing dental extractions: a randomized prospective clinical study. Journal of Oral and Maxillofacial Surgery 2003;61(12):1432‐5. [PubMed] [Google Scholar]

CTRI/2017/09/009784 {unpublished data only}

• CTRI/2017/09/009784. Effectiveness of topical haemocoagulase as a haemostatic agent in children undergoing extraction of deciduous teeth – a split‐oral fissure, randomized, double‐blind, clinical trial. world wide web.ctri.nic.in (first received 15 September 2017).

Henderson 1998 {published data just}

• Henderson NJ, Crawford PJ, Reeves BC. A randomised trial of calcium alginate swabs to command blood loss in 3‐5‐twelvemonth‐old children. British Dental Periodical 1998;184(four):187‐ninety. [PubMed] [Google Scholar]

Howard 1973 {published data just}

• Howard D, Whitehurst VE, Bingham R, Stanback J. The use of bucrylate to attain hemostasis in molar extraction sites. Oral Surgery 1973;35(6):762‐5. [PubMed] [Google Scholar]

Kjellman 1973 {published data but}

• Kjellman O. Apernyl as alveolar inlay in connection with the removal of impacted 3rd molars of the lower jaw. A clinical double blind investigation of 100 patients. Swedish Dental Journal 1973;66(two):197‐200. [PubMed] [Google Scholar]

Medeiros 2011 {published data only}

• Medeiros FB, Andrade Air conditioning, Angelis GA, Conrado VC, Timerman Fifty, Farsky P, et al. Bleeding evaluation during single molar extraction in patients with coronary artery illness and acetylsalicylic acid therapy suspension: a prospective, double‐blinded, and randomized study. Journal of Oral and Maxillofacial Surgery 2011;69(12):2949‐55. [PubMed] [Google Scholar]

Pinsent 1986 {published data only}

• Pinsent RJ, Baker GP, Ives G, Davey RW, Jonas South. Does arnica reduce pain and bleeding after dental extraction?. British Homeopathic Enquiry Grouping Communications 1986;15:3‐11. [Google Scholar]

Zhou 1985 {published data simply}

• Zhou RJ. 1985 Aug five ( 8) 483‐484. Prevention and handling of hemorrhage after extraction of teeth by using the pulvis of cibotium barometz‐alum burn. Zhong xi yi jie he za zhi [Chinese Journal of Mod Developments in Traditional Medicine] 1985;v(eight):483‐4. [PubMed] [Google Scholar]

Additional references

Abdullah 2014

• Abdullah WA, Khalil H. Dental extraction in patients on warfarin treatment. Periodical of Clinical, Cosmetic and Investigational Dentistry 2014;6:65‐9. [PMC costless article] [PubMed] [Google Scholar]

Aframian 2007

• Aframian DJ, Lalla RV, Peterson DE. Management of dental patients taking common hemostasis‐altering medications. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2007;103 Suppl:S45 e1‐xi. [PubMed] [Google Scholar]

Al‐Bahlani 2001

• Al‐Bahlani Due south, Sherriff A, Crawford PJ. Tooth extraction, haemorrhage and pain control. Journal of the Royal College of Surgeons of Edinburgh 2001;46(5):261‐4. [PubMed] [Google Scholar]

Al‐Belasy 2003

• Al‐Belasy FA, Amer MZ. Hemostatic consequence of n‐Butyl‐2‐Cyanoacrylate (Histoacryl) glue in warfarin‐treated patients undergoing oral surgery. Journal of Oral and Maxillofacial Surgery 2003;61:1405‐9. [PubMed] [Google Scholar]

Amer 2014

• Amer MZ, Mourad SI, Salem As, Abdelfadil E. Correlation between International Normalized Ratio values and sufficiency of 2 unlike local hemostatic measures in anticoagulated patients. European Journal of Dentistry 2014;8:475‐80. [PMC complimentary article] [PubMed] [Google Scholar]

Anderson 2013

• Anderson JAM, Brewer A, Creagh D, Hook S, Mainwaring J, McKernan A, et al. Guidance on the dental direction of patients with haemophilia and congenital bleeding disorders. British Dental Journal 2013;215:497‐504. [PubMed] [Google Scholar]

Antoszewski 1972

• Antoszewski Z. Cepevit‐K preparation in controlling hemorrhages and haemorrhage following molar extraction. Polski tygodnik lekarski 1972;27(47):1861‐62. [PubMed] [Google Scholar]

Auluck 2004

• Auluck A, Pai KM, Bhat KS, Thoppil PS. Unusual postal service‐extraction hemorrhage in a cardiac patient: a case report. Journal of the Canadian Dental Clan 2004;70(11):769‐73. [PubMed] [Google Scholar]

Bajkin 2014

• Bajkin BV, Selaković SD, Mirković SM, Šarčev IN, Tadič AJ, Milekič BR. Comparison of efficacy of local hemostatic modalities in anticoagulated patients undergoing tooth extractions. Vojnosanitetski pregled 2014;71(12):1097‐101. [PubMed] [Google Scholar]

Baumann 2009

• Baumann P, Schumacher H, Hüsing J, Luntz South, Knaebel HP. A randomized, controlled, prospective trial to evaluate the haemostatic consequence of Lyostypt versus Surgicel in arterial featherbed anastomosis: "COBBANA" trial. Trials 2009;x:91. [PMC gratuitous commodity] [PubMed] [Google Scholar]

Chiapasco 1993

• Chiapasco Grand, Cicco L, Marrone K. Side effects and complications associated with 3rd tooth surgery. Oral Surgery, Oral Medicine, and Oral Pathology 1993;76(four):412‐20. [PubMed] [Google Scholar]

Cocero 2015

• Cocero Northward, Pucci F, Messina One thousand, Pollio B, Mozzati M, Bergamasco L. Autologous plasma rich in growth factors in the prevention of severe bleeding later on teeth extractions in patients with bleeding disorders: a controlled comparison with fibrin glue. Blood Transfusion 2015;thirteen(2):287‐94. [PMC free commodity] [PubMed] [Google Scholar]

Deeks 2011

• Deeks JJ, Higgins JPT, Altman DG. Affiliate 9: Analysing data and undertaking meta‐analyses. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.ane.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from world wide web.cochrane‐handbook.org.

DRKS00009286

• Ermer 1000. Postal service‐operative bleeding in dento‐alveolar surgery. Bachelor from http://www.drks.de/DRKS00009286 (accessed 31 March 2016).

Egger 1997

• Egger Chiliad, Davey Smith 1000, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. British Medical Journal 1997;315(7109):629‐34. [PMC free article] [PubMed] [Google Scholar]

Fetkowska‐Mielnik 1969

• Fetkowska‐Mielnik K, Komorowska A. Clinical evaluation of the results of treatment of postextraction bleeding with new drugs E.A.C.A., styptanon. Czasopismo stomatologiczne 1969;22(2):179‐83. [PubMed] [Google Scholar]

Funayama 1994

• Funayama M, Kumagai T, Saito One thousand, Watanabe T. Asphyxial death acquired past postextraction hematoma. American Journal of Forensic Medicine and Pathology 1994;fifteen:87–90. [PubMed] [Google Scholar]

Glick 2013

• Glick JB, Kaur RR, Siegel D. Achieving hemostasis in dermatology‐Part Two: Topical hemostatic agents. Indian Dermatology Online Periodical 2013;4(3):172‐6. [PMC gratis commodity] [PubMed] [Google Scholar]

GRADEpro GDT 2014 [Calculator plan]

• GRADE Working Group, McMaster Academy. GRADEpro GDT. Version accessed 22 March 2016. Hamilton (ON): GRADE Working Grouping, McMaster University, 2014.

Higgins 2011

• Higgins JPT, Greenish Southward (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [March 2011], The Cochrane Collaboration, 2011. Available from world wide web.cochrane‐handbook.org.

Higginson 2007

• Higginson I. Post Extraction Dental Haemorrhage. EMed Handbook ‐ Cork Emergency Medicine, Available from http://www.emed.ie/HE‐ENT/Dental/Dental_Haemorrhage_Post_Extraction.php#typ (accessed 16 March 2016).

Howe 2013

• Howe N, Cherpelis B. Obtaining rapid and effective hemostasis: Part I. Update and review of topical hemostatic agents. Journal of the American University of Dermatology 2013;69(5):659.e1‐17. [PubMed] [Google Scholar]

Iwabuchi 2014

• Iwabuchi H, Imai Y, Asanami S, Shirakawa 1000, Yamane GY, Ogiuchi H, et al. Evaluation of postextraction bleeding incidence to compare patients receiving and not receiving warfarin therapy: a cross‐sectional, multicentre, observational study. BMJ Open 2014;4(12):e005777. [PMC complimentary article] [PubMed] [Google Scholar]

Jensen 1974

• Jensen S. Hemorrhage after oral surgery. An analysis of 103 cases. Oral Surgery, Oral Medicine, and Oral Pathology 1974;37(ane):2‐16. [PubMed] [Google Scholar]

Joshi 2014

• Joshi SA, Gadre KS, Halli R, Shandilya R. Topical utilize of Hemocoagulase (Reptilase): a simple and effective fashion of managing mail service‐extraction haemorrhage. Annals of Maxillofacial Surgery 2014;four(one):119. [PMC free commodity] [PubMed] [Google Scholar]

Kataoka 2016

• Kataoka T, Hoshi K, Ando T. Is the HAS‐BLED score useful in predicting post‐extraction bleeding in patients taking warfarin? A retrospective cohort written report. BMJ Open up 2016;6(3):e010471. [DOI: 10.1136/bmjopen-2015-010471] [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]

Khomiachenko 1978

• Khomiachenko VP. Use of aminocaproic acid for stopping the hemorrhage after tooth extraction. Stomatologiia (Mosk) 1978;57(1):91. [PubMed] [Google Scholar]

Lefebvre 2011

• Lefebvre C, Manheimer E, Glanville J. Chapter six: Searching for studies. In: Higgins JP, Light-green Southward, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version five.one.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Leonard 1995

• Leonard MS. An arroyo to some dilemmas and complications of office oral surgery. Australian Dental Periodical 1993;40(3):159‐63. [PubMed] [Google Scholar]

Lockhart 2003

• Lockhart Atomic number 82, Gibson J, Pond SH, Leitch J. Dental direction considerations for the patient with an acquired coagulopathy. Function 1: Coagulopathies from systemic affliction. British Dental Journal 2003;195(viii):439‐45. [PubMed] [Google Scholar]

Malik 2008

• Malik NA. Textbook of Oral and Maxillofacial Surgery. Second Edition. New Delhi: Jaypee Brothers Medical Publishers, 2008. [Google Scholar]

Marini 1966

• Marini MP, Arturi F, Crolle K. Therapy of post‐extraction hemorrhages in hemophiliac patients with epsilon‐aminocaproic acid (EACA). Haematologica 1966;51(7):553‐68. [PubMed] [Google Scholar]

Martineau 1989

• Martineau C. Hemorrhage in the dental office. Study of local hemostatic treatment. Data dentaire 1989;71(40):3861‐69. [PubMed] [Google Scholar]

McCormick 2014a

• McCormick NJ, Moore UJ, Meechan JG, Norouzi M. Haemostasis. Role 2: Medications that affect haemostasis. Dental Update 2014;41(five):395‐405. [PubMed] [Google Scholar]

McCormick 2014b

• McCormick NJ, Moore UJ, Meechan JG. Haemostasis. Part 1: The direction of postal service‐extraction bleeding. Dental Update 2014;41(4):290‐ii, 294‐six. [PubMed] [Google Scholar]

McDonnell 2013

• McDonnell D. Bleeding sockets. British Dental Periodical 2013;215:104. [PubMed] [Google Scholar]

Mingarro‐de‐León A 2014

• Mingarro‐de‐León A, Chaveli‐López B, Gavaldá‐Esteve C. Dental management of patients receiving anticoagulant and/or antiplatelet handling. Journal of Clinical and Experimental Dentistry 2014;6(2):e155‐61. [PMC complimentary article] [PubMed] [Google Scholar]

Minkin 2015

• Minkin P, Bertetti R, Lindsey S, Bovino B. Management of tooth extraction in a patient with a rare bleeding disorder associated with Hermansky‐Pudlak syndrome: a case report. Journal of Oral and Maxillofacial Surgery 2015;73(2):219‐23. [PubMed] [Google Scholar]

Morimoto 2004

• Morimoto Y, Yoshioka A, Imai Y, Takahashi Y, Minowa H, Kirita T. Haemostatic management of intraoral bleeding in patients with built deficiency of alpha2‐plasmin inhibitor or plasminogen activator inhibitor‐1. Haemophilia 2004;10(5):669‐74. [PubMed] [Google Scholar]

Neuner 1968

• Neuner O, Schegg HK. Therapy of hemorrhage post-obit extractions. Schweizerische Monatsschrift fur Zahnheilkunde 1968;78(10):974‐82. [PubMed] [Google Scholar]

Pavek 1976

• Pavek 5. Evaluation of the hemostatic effect of Dicynon in dentoalveolar surgery. Ceskoslovenska stomatologie 1976;76(ane):56‐64. [PubMed] [Google Scholar]

Perdigão 2012

• Perdigão JP, Almeida PC, Rocha TD, Mota MR, Soares EC, Alves AP, et al. Postoperative bleeding after dental extraction in liver pretransplant patients. Journal of Oral and Maxillofacial Surgery 2012;70:e177‐84. [PubMed] [Google Scholar]

Pippi 2015

• Pippi R, Santoro Grand, Cafolla A. The effectiveness of a new method using an extra‐alveolar hemostatic agent after dental extractions in older patients on oral anticoagulation treatment: an intrapatient study. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology 2015 [Epub ahead of impress];120(ane):15‐21. [DOI: 10.1016/j.oooo.2015.02.482] [PubMed] [CrossRef] [Google Scholar]

RevMan 2014 [Reckoner programme]

• The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Rokicka‐Milewska 1966

• Rokicka‐Milewska R, Krajewska‐Martel A, Dyszy‐Laube B. Application of epsilon‐aminocaproic acid for oral mucosal bleeding in hemophiliacs. Polskie Archiwum Medycyny Wewnetrznej 1966;37(iv):445‐50. [PubMed] [Google Scholar]

Saltykova 1974

• Saltykova ZA, Tarasova LN. The use of new hemostatic drug in dental exercise. Stomatologiia 1974;53(1):85‐6. [PubMed] [Google Scholar]

Scarano 2014

• Scarano A, Sinjari B, Murmura Yard, Mijiritsky E, Iaculli F, Mortellaro C, et al. Hemostasis control in dental extractions in patients receiving oral anticoagulant therapy: an arroyo with calcium sulfate. Journal of Craniofacial Surgery 2014;25(3):843‐half-dozen. [PubMed] [Google Scholar]

Sharma 2017

• Sharma South, Kale TP, Balihallimath LJ, Motimath A. Evaluating effectiveness of axiostat hemostatic material in achieving hemostasis and healing of extraction wounds in patients on oral antiplatelet drugs. Periodical of Gimmicky Dental Practise 2017;xviii(9):802‐6. [PUBMED: 28874645] [PubMed] [Google Scholar]

Soltani 2014

• Soltani R, Haghighat A, Fanaei M, Asghari Thou. Evaluation of the outcome of green tea extract on the prevention of gingival bleeding later posterior mandibular teeth extraction: a randomized controlled trial. Show‐Based Complementary and Alternative Medicine 2014; Vol. 2014, upshot article 857651. [DOI: 10.1155/2014/857651] [PMC free article] [PubMed] [CrossRef]

Stanca 2010

• Stanca CM, Montazem AH, Lawal A, Zhang JX, Schiano TD. Intranasal eesmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial. Journal of Oral and Maxillofacial Surgery 2010;68:138‐43. [PubMed] [Google Scholar]

Szpirglas 1979

• Szpirglas H, Gotte P, Tsamis J, Fraccari F. Stomatological hemorrhages; hemostasis with GRF (gelatin‐resorcin‐formol). Minerva stomatologica 1979;28(4):285‐7. [PubMed] [Google Scholar]

Torteli 1965

• Torteli A, Hattyasy D. Apply of "reptilase" in postoperative hemorrhages of the dental apparatus. Schweizerische Monatsschrift fur Zahnheilkunde 1965;75(11):1214‐21. [PubMed] [Google Scholar]

Traver 2006

• Traver MA, Assimos DG. New generation tissue sealants and hemostatic agents: innovative urologic applications. Reviews in Urology 2006;8(3):104‐11. [PMC complimentary article] [PubMed] [Google Scholar]

Trentalancia 1967

• Trentalancia Thousand. The use of 5‐oxytryptamine in mail service‐extraction hemorrhages. Dental Cadmos 1967;35(10):1377‐90. [PubMed] [Google Scholar]

Academy of Cambridge

• University of Cambridge Academy Dental Do. Persistent haemorrhage post-obit dental extraction. Bachelor from http://www.dental.cam.ac.britain/info‐nhs/dis‐post‐extraction‐haemorrhage. (accessed on 16 March 2016).

Van Galen 2014

• Galen KPM, Engelen ET, Mauser‐Bunschoten EP, Es RJJ, Schutgens REG. Antifibrinolytic therapy for preventing oral bleeding in patients with a hemophilia or Von Willebrand disease undergoing oral or dental procedures. Cochrane Database of Systematic Reviews 2014, Issue 12. [DOI: 10.1002/14651858.CD011385] [CrossRef] [Google Scholar]

Wahl 2016

• Wahl MJ, Schmitt MM. Postextraction bleeding in a patient taking antithrombotics: report of a case. General Dentistry 2016;64(3):60‐3. [PUBMED: 27148659] [PubMed] [Google Scholar]

Wells 2000

• Wells D, Capes J, Powers M. Complications of dentoalveolar surgery. In: Fonseca R editor(south). Oral and Maxillofacial Surgery. Vol. ane, Philadelphia: WB Saunders, 2000:421‐38. [Google Scholar]

Worthington 2015

• Worthington H, Clarkson J, Weldon J. Priority oral wellness enquiry identification for clinical determination‐making. Evidence‐based Dentistry 2015;16(3):69‐71. [PubMed] [Google Scholar]

Yagyuu 2017

• Yagyuu T, Kawakami K, Ueyama Y, Imada M, Kurihara 1000, Matsusue Y, et al. Risks of postextraction bleeding later receiving direct oral anticoagulants or warfarin: a retrospective cohort study. BMJ Open up 2017;7:e015952. [DOI: 10.1136/bmjopen-2017-015952] [PMC free article] [PubMed] [CrossRef] [Google Scholar]

References to other published versions of this review

Sumanth 2015

• Sumanth KN, Prashanti East, Aggarwal H, Kumar P, Kiran Kumar Krishanappa S. Interventions for managing post‐extraction bleeding. Cochrane Database of Systematic Reviews 2015, Issue 10. [DOI: ten.1002/14651858.CD011930] [CrossRef] [Google Scholar]

Sumanth 2016

• Kumbargere Nagraj Southward, Prashanti E, Aggarwal H, Lingappa A, Muthu MS, Kiran Kumar Krishanappa S, et al. Interventions for treating mail service‐extraction bleeding. Cochrane Database of Systematic Reviews 2016, Issue 6. [DOI: 10.1002/14651858.CD011930.pub2] [PubMed] [CrossRef] [Google Scholar]

lindseyviiii1983.blogspot.com

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494262/

Share this post